Cardiovascular and noncardiovascular mortality among patients starting dialysis.
暂无分享,去创建一个
Frits R Rosendaal | F. Dekker | F. Rosendaal | J. Wetzels | F. Collart | P. Finne | K. Jager | J. D. De Meester | P. V. van Dijk | J. Heaf | D. Grootendorst | D. Ansell | Kitty J Jager | Friedo W Dekker | Patrik Finne | Frederic Collart | Paul C van Dijk | Johan De Meester | David Ansell | James G Heaf | Jack F M Wetzels | Dinanda J de Jager | Diana C Grootendorst | Lonneke M J Tomas | Dinanda J. de Jager | D. J. de Jager | L. J. Tomas
[1] K. D. Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] Y. Yuzawa,et al. Aspects of immune dysfunction in end-stage renal disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[3] R. Foley,et al. Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[4] J. Sowers,et al. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. , 2006, Advances in chronic kidney disease.
[5] Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] W. Bloembergen,et al. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. , 2001, Journal of the American Society of Nephrology : JASN.
[7] M. Margaglione,et al. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study. , 2009, Atherosclerosis.
[8] A. Collins,et al. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. , 1998, The New England journal of medicine.
[9] M. Rocco,et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. , 2000, Kidney international.
[10] A. Garg,et al. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. , 2002, Kidney international.
[11] R Cornet,et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] R. Foley. Infections and cardiovascular disease in patients with chronic kidney disease. , 2006, Advances in chronic kidney disease.
[13] N. Kutner,et al. Significance of frailty among dialysis patients. , 2007, Journal of the American Society of Nephrology : JASN.
[14] P. Boyle,et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study , 1999, The Lancet.
[15] L. Fried,et al. Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[16] T. Stompór. An Overview of the Pathophysiology of Vascular Calcification in Chronic Kidney Disease , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[17] L. Fitzpatrick,et al. Vascular calcification. , 1999, Current opinion in nephrology and hypertension.
[18] F. Dekker,et al. Association of serum fetuin-A levels with mortality in dialysis patients. , 2007, Kidney international.
[19] C. Zoccali,et al. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] R. Écochard,et al. Effect of age, gender, and diabetes on excess death in end-stage renal failure. , 2007, Journal of the American Society of Nephrology : JASN.
[21] R. Foley,et al. Epidemiology of cardiovascular disease in chronic renal disease , 2000 .
[22] Deeb N Salem,et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.
[23] F. Dekker,et al. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] C. Wanner,et al. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[25] M. Ketteler,et al. Novel insights into vascular calcification. , 2006, Kidney international. Supplement.
[26] R. Wolfe,et al. Causes of death in dialysis patients: racial and gender differences. , 1994, Journal of the American Society of Nephrology : JASN.
[27] David C. Murray,et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. , 1995, Kidney international.
[28] Charles E. McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[29] T. Ekström,et al. Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease? , 2007, Journal of internal medicine.
[30] F. Dekker,et al. The European Registry: Where do We Stand? , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[31] J. Vandenbroucke,et al. Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] F. Dekker,et al. Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] Robert M Califf,et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.
[34] B. Scribner,et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. , 1974, The New England journal of medicine.
[35] M. Rocco,et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. , 2004, Kidney international.